Where does Ombraz, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Ombraz, Inc. ranks #49,283 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Ombraz, Inc. hold?

Ombraz, Inc. holds 5 US utility patents granted between 2023 and 2025, spanning 1 technology areas.

What is Ombraz, Inc.'s Innovation Score?

Ombraz, Inc. has an Innovation Score of 32.6 out of 100 (42nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Ombraz, Inc. focus on?

Ombraz, Inc.'s top technology area is G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses) with 1 patents, ranking #272 of 397 assignees active in that subclass. Grants appear in 1 CPC subclasses total.

Is Ombraz, Inc.'s patent grant rate increasing or decreasing?

Insufficient historical data is available to calculate a velocity trend for Ombraz, Inc..

What does claim depth mean for Ombraz, Inc.'s patents?

Ombraz, Inc.'s patents average 4.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Ombraz, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

Ombraz, Inc.

USPTO PatentsView assignee record - 5 granted patents across 1 technology areas, recorded in grant years 2023–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Ombraz ranks #49,283 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 1 technology areas.

#49,283
of 49,997 US assignees by volume: 42nd percentile
by Innovation Score (32.6/100): 4.8
avg claims per patent

USPTO PatentsView assignee plate

Corpus R49283 · US Corporation #49,283 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-SPARSE · TYPE-USCORP · SPAN-YRS · BOOK-RICH

GRANTS-MICRO 5 grants
BOTTOM-DECILE #49,283/49,997
PHOTO-FINISH Oklahoma Blood…
CPC-NARROW G02C · 1 areas
INNOV-THIN 32.6/100
CLAIMS-SPARSE 4.8 claims/avg
TYPE-USCORP US Corporation
SPAN-YRS 2023–2025 · 3y
BOOK-RICH 9/10 fields

Nearest grant-volume peer: Oklahoma Blood Institute (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ombraz’s 32.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 6.2 pts (19%) Velocity 20.0 pts (61%) Breadth 3.5 pts (11%) Claim depth 2.9 pts (9%)

Qualcomm Incorporated · highest

85
Ombraz · this assignee

33
3D Lighting… · lowest

7

What this shows Ombraz's Innovation Score is 32.6/100 (42nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Ombraz?

Each dot is one of Ombraz’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ombraz’s own 4.8 claims/patent is at or below the 16.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Ombraz vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ombraz's grants concentrate

Ombraz, Inc. is a focused PatentsView assignee: 1 CPC subclasses with 20% of grants classified under G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses). Peak complete grant year is 2024 (2 grants) versus a trough of 1 in 2023. By volume, Ombraz sits between Oklahoma Blood Institute and Omnia Medical, LLC.

Ombraz's three-year grant acceleration

Ombraz, Inc. shows 3 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Oklahoma Blood In…

5
Olea Networks

5
Olfactive Biosolu…

5
Olympian Gaming

5
Omcare

5
Omni Powertrain

5
Omniguide

5
Omnia Medical

5
Ombraz ◀

5

What this shows Ombraz holds 5 patents at rank #49,356, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Ombraz

By rank, the assignees closest to #49,356 in granted patent volume.

Leaders in G02C (Spectacles)

Other assignees with the most granted patents in Ombraz's primary technology class.

Ombraz's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

33 42nd percentile higher than 42% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2023–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2023–2019 baseline. Full figures in the table below.

View data table

Ombraz, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2023	1	20.0%
2024	2	40.0%
2025partial year	2	40.0%

Which technologies does Ombraz, Inc. patent most?

G02C - SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses 1

Top 1 of 1 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Ombraz, Inc.'s patent record in context - here's where to go next.

Ombraz, Inc.'s lead technology class is G02C (SPECTACLES; Sunglasses OR Goggles Insofar AS They Have THE Same Features AS SPECTACLES; Contact Lenses), 20% of its portfolio - see every assignee active in that class. Explore G02C
Ranked #49,283 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Ombraz, Inc. against Oklahoma Blood Institute, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent , US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.